Home » Topics » BioWorld

BioWorld
RSS

COURT DEALS SETBACK TO KODAK ON PCR

Dec. 4, 1991

CIBA SUES TO SNUFF ALZA'S NICOTINE PATCH

Dec. 3, 1991

AGOURON BEGINS TRIALS OF PSORIASIS DRUG

Dec. 3, 1991

FDA APPROVES r-GCR FOR PHASE III

Dec. 3, 1991

TUFTS TO TEST DENSE FIBRILLAR COLLAGEN

Dec. 3, 1991

XOMA TRIES TO BLOCK CENTOXIN

Dec. 3, 1991

AMYLIN FILES SILENT IPO

Dec. 3, 1991

GENE DELIVERY WITHOUT RETROVIRUSES

Dec. 3, 1991

EARLY TRIGGER OF ARTHRITIS TARGETED

Dec. 3, 1991

BILL PROPOSES ORPHAN DRUG LIMITS

Dec. 2, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...